ChemFeeds Site Navigation:
Journal Selection:
Search:

99) Macrophage- and Microglia-Secreted TNF{alpha} Inhibits oHSV Efficacy (Clinical Cancer Research) Wednesday July 15th 2015


100) Targeting Glutamine Metabolism in Breast Cancer (Clinical Cancer Research) Wednesday July 15th 2015


101) Preclinical Development of an anti-LY6E Antibody-Drug Con{#x0237}ugate (Clinical Cancer Research) Wednesday July 15th 2015


102) Ancient Retrovirus Targeted by Engineered T Cells in Melanoma (Clinical Cancer Research) Wednesday July 15th 2015


103) Regulation of STAT3 and c-FLIPL in BRAF-Mutant Colon Cancer (Clinical Cancer Research) Wednesday July 15th 2015


104) PI3K/mTOR Inhibitors in Osteosarcoma (Clinical Cancer Research) Wednesday July 15th 2015


105) PI3K/mTOR Inhibition in Pituitary Adenomas (Clinical Cancer Research) Wednesday July 15th 2015


106) Plasma-Based EGFR Mutation Analysis from the FASTACT-2 Study (Clinical Cancer Research) Wednesday July 15th 2015


107) MMRN1 as Adverse Marker in AML (Clinical Cancer Research) Wednesday July 15th 2015


108) Autologous Sarcoma Cell Vaccines (Clinical Cancer Research) Wednesday July 15th 2015


109) Abiraterone PSA-Survival Model Predicts Survival Outcomes (Clinical Cancer Research) Wednesday July 15th 2015


110) Phase I Study of Pilaralisib in CLL or Lymphoma (Clinical Cancer Research) Wednesday July 15th 2015


111) Hepatic Artery CAR-T Infusions (Clinical Cancer Research) Wednesday July 15th 2015


112) PD-L1 Expression and TILs in MAPKi-Treated Melanoma Patients (Clinical Cancer Research) Wednesday July 15th 2015


113) Immune Recovery after Flu-TBI versus ATG-TLI (Clinical Cancer Research) Wednesday July 15th 2015


114) Nanotechnology in Cancer (Clinical Cancer Research) Wednesday July 15th 2015


115) Anti-CD137 Antibody in Cancer Immunotherapy (Clinical Cancer Research) Wednesday July 15th 2015


116) Tumor-Promoting Role of MDSCs (Clinical Cancer Research) Wednesday July 15th 2015


117) Fusions Genes Predict Therapeutic Sensitivity (Clinical Cancer Research) Wednesday July 15th 2015


118) Does It MEK a Difference? Immune Effects of Targeted Therapy (Clinical Cancer Research) Wednesday July 15th 2015


119) CARs: From Model T to the Tesla (Clinical Cancer Research) Wednesday July 15th 2015


120) Correction: Survivin as a Prognostic Marker for Urothelial Carcinoma of the Bladder: A Multicenter External Validation Study (Clinical Cancer Research) Tuesday June 30th 2015


121) Correction: Low Levels of Her2/neu Expressed by Ewing's Family Tumor Cell Lines Can Redirect Cytokine-Induced Killer Cells (Clinical Cancer Research) Tuesday June 30th 2015


122) Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel--Response (Clinical Cancer Research) Tuesday June 30th 2015


123) Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel--Letter (Clinical Cancer Research) Tuesday June 30th 2015


124) K19, a Cancer Stem Cell Marker in Human HCC (Clinical Cancer Research) Tuesday June 30th 2015


125) miR-30s Inhibit Premetastatic Vascular Hyperpermeability (Clinical Cancer Research) Tuesday June 30th 2015


126) Identification of a Candidate Gene Panel for Prostate Cancer (Clinical Cancer Research) Tuesday June 30th 2015


127) PD-L1 and T-cell Infiltrates in Melanoma Tumors (Clinical Cancer Research) Tuesday June 30th 2015


128) Targeting IL11R in Human Leukemia and Lymphoma (Clinical Cancer Research) Tuesday June 30th 2015


129) The Suppressive and Dysfunctional Immune Contexture in RCC (Clinical Cancer Research) Tuesday June 30th 2015


130) DNA Methylation Profiling in PPGL. Novel Prognostic Markers (Clinical Cancer Research) Tuesday June 30th 2015


131) New Validated Prognostic Model for EATL (Clinical Cancer Research) Tuesday June 30th 2015


132) Local Recurrence and the Effects of BMP-2 in Osteosarcoma (Clinical Cancer Research) Tuesday June 30th 2015


133) CD19CAR/CMV Bispecific T Cells (Clinical Cancer Research) Tuesday June 30th 2015


134) TH-302 and Radiotherapy Monitored by [18F]HX4 Imaging (Clinical Cancer Research) Tuesday June 30th 2015


135) Regorafenib and Cetuximab Overcome Resistance to Cetuximab (Clinical Cancer Research) Tuesday June 30th 2015


136) Antitumor Activity of Novel Glycan Monoclonal Antibodies (Clinical Cancer Research) Tuesday June 30th 2015


137) Boosting Virus Specificity of CAR-Virus-Specific CTLs (Clinical Cancer Research) Tuesday June 30th 2015


138) Reactive Stroma Signature Predicts Chemoresistance (Clinical Cancer Research) Tuesday June 30th 2015


139) Antiproliferative Effects of Lapatinib in Early Breast Cancer (Clinical Cancer Research) Tuesday June 30th 2015


140) Afatinib and Trastuzumab with Neoadjuvant Chemotherapy (DAFNE) (Clinical Cancer Research) Tuesday June 30th 2015


141) Heterogeneity and Resistance (Clinical Cancer Research) Tuesday June 30th 2015


142) Neoadjuvant as Future for Drug Development in Breast Cancer (Clinical Cancer Research) Tuesday June 30th 2015


143) Targeting Cyclin D-CDK4/6 for Cancer Therapy (Clinical Cancer Research) Tuesday June 30th 2015


144) Overcoming Radiation Resistance (Clinical Cancer Research) Tuesday June 30th 2015


145) Pembrolizumab for Advanced or Unresectable Melanoma (Clinical Cancer Research) Tuesday June 30th 2015


146) To B(MP-2) or Not To B(MP-2): Cytokines and Tumor Surgery (Clinical Cancer Research) Tuesday June 30th 2015


147) HER Targeting in HER2-Negative Breast Cancer (Clinical Cancer Research) Tuesday June 30th 2015


148) Paving the Way for Circulating Tumor Cells (Clinical Cancer Research) Tuesday June 30th 2015


149) Metabolic Adaptation to Chemotherapy in Colon Cancer (Clinical Cancer Research) Sunday June 14th 2015


150) HPV Antibodies Predict Survival in OPC Patients (Clinical Cancer Research) Sunday June 14th 2015


151) LKB1 in KRAS-Mutant NSCLC (Clinical Cancer Research) Sunday June 14th 2015


152) Chemokines and Chemokine Receptors in Ovarian Cancer (Clinical Cancer Research) Sunday June 14th 2015


153) Tryptophan Catabolism in ATL (Clinical Cancer Research) Sunday June 14th 2015


154) Gene Expression Profiling in CTCL (Clinical Cancer Research) Sunday June 14th 2015


155) AZD6094 in PRCC PDX Models (Clinical Cancer Research) Sunday June 14th 2015


156) Anti-CD38 Therapy for Refractory Multiple Myeloma (Clinical Cancer Research) Sunday June 14th 2015


157) Dual PI3K/mTOR Inhibitor and Radiation Sensitization (Clinical Cancer Research) Sunday June 14th 2015


158) Methionine Stress Sensitizes to TRAIL Receptor-2 Agonists (Clinical Cancer Research) Sunday June 14th 2015


159) CTC, Triple-Negative Breast Cancer, Apoptosis, Tigatuzumab (Clinical Cancer Research) Sunday June 14th 2015


160) Estrogen Receptor Expression Predicts Increased Late Recurrence (Clinical Cancer Research) Sunday June 14th 2015


161) CD44 Isoforms Predict Response to Anti-CD44 Treatment (Clinical Cancer Research) Sunday June 14th 2015


162) Sequential Crizotinib and Ceritinib (Clinical Cancer Research) Sunday June 14th 2015


163) Afatinib and Trastuzumab in HER2-Positive Breast Cancer (Clinical Cancer Research) Sunday June 14th 2015


164) Phase I Trial with Antibody BI-505 in Myeloma (Clinical Cancer Research) Sunday June 14th 2015


165) Phase II Trial of Tigatuzumab/nab-PAC in Patients with Triple-Negative Breast Cancer (Clinical Cancer Research) Sunday June 14th 2015


166) Vorinostat and 131I-MIBG in Neuroblastoma (Clinical Cancer Research) Sunday June 14th 2015


167) HyperCVAD plus Everolimus in Patients with ALL (Clinical Cancer Research) Sunday June 14th 2015


168) Phase I Study of Enoticumab (REGN421) in Solid Tumors (Clinical Cancer Research) Sunday June 14th 2015


169) Targeting FGFR Signaling in Cancer (Clinical Cancer Research) Sunday June 14th 2015


170) Management of Side Effects of SMO Inhibitor Therapy for aBCC (Clinical Cancer Research) Sunday June 14th 2015


171) BCL-2 Proteins as Chemotherapy Targets (Clinical Cancer Research) Sunday June 14th 2015


172) FDA Approval of Belinostat for Relapsed or Refractory PTCL (Clinical Cancer Research) Sunday June 14th 2015


173) Vertical HER2 Inhibition in the Clinic (Clinical Cancer Research) Sunday June 14th 2015


174) CD38-Targeted Immunochemotherapy in Refractory Myeloma (Clinical Cancer Research) Sunday June 14th 2015


175) Immuno-oncology: From Treg to Checkpoint Antibodies (Clinical Cancer Research) Sunday June 14th 2015


176) Correction: Gene Signature-Guided Dasatinib Therapy in Metastatic Breast Cancer (Clinical Cancer Research) Sunday May 31st 2015


177) Correction: Validation of a Standardized Method for Enumerating Circulating Endothelial Cells and Progenitors: Flow Cytometry and Molecular and Ultrastructural Analyses (Clinical Cancer Research) Sunday May 31st 2015


178) Clonal Evolution in Primary and Metastatic Tumors (Clinical Cancer Research) Sunday May 31st 2015


179) CD8+ T Cells in NSCLC (Clinical Cancer Research) Sunday May 31st 2015


180) Beta-HPV and UV Damage in Cutaneous SCC during BRAF Therapy (Clinical Cancer Research) Sunday May 31st 2015


181) RB Pathway Mutations in Early-Stage Lung Adenocarcinoma (Clinical Cancer Research) Sunday May 31st 2015


182) AXL Is a Molecular Target in HNSCC (Clinical Cancer Research) Sunday May 31st 2015


183) Biopsy Test for Discriminating Prostate Cancer Outcomes (Clinical Cancer Research) Sunday May 31st 2015


184) YAP1 Mediates EGFR Overexpression and Chemoresistance in Esophageal Cancer (Clinical Cancer Research) Sunday May 31st 2015


185) ERG Regulation of AKR1C3 Androgen Production and AR Activity (Clinical Cancer Research) Sunday May 31st 2015


186) Acquired Resistance to Bcl-2 and MDM2 Inhibitors (Clinical Cancer Research) Sunday May 31st 2015


187) TBI-Induced IL12 Augments Tc17 Activity (Clinical Cancer Research) Sunday May 31st 2015


188) Targeting Syk in Waldenstrom Macroglobulinemia (Clinical Cancer Research) Sunday May 31st 2015


189) PIK3CA Mutations Predictive of Bad Response in Cervix Cancer (Clinical Cancer Research) Sunday May 31st 2015


190) Optimal Patient Selection for Trastuzumab Treatment in AGC (Clinical Cancer Research) Sunday May 31st 2015


191) Rigidity Analysis Affects Treatment of Skeletal Metastasis (Clinical Cancer Research) Sunday May 31st 2015


192) Diffusion-Weighted MRI for Lymphoma Restaging (Clinical Cancer Research) Sunday May 31st 2015


193) NRF2 Pathway and Chemotherapy in Lung Squamous Cell Carcinoma (Clinical Cancer Research) Sunday May 31st 2015


194) Multiparameter Characterization of Circulating Tumor Cells (Clinical Cancer Research) Sunday May 31st 2015


195) Phase I Trial of ADI-PEG 20 Plus Docetaxel (Clinical Cancer Research) Sunday May 31st 2015


196) Angiotensin System Inhibitors in Renal Cell Carcinoma (Clinical Cancer Research) Sunday May 31st 2015


View: prev | next


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()